Amber A Rivera Selected Research

Intestinal Obstruction (Obstruction, Intestinal)

1/2021

SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amber A Rivera Research Topics

Disease

5	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2018
2	Constipation 01/2021 - 01/2018
2	Diarrhea 01/2021 - 01/2018
2	Infections 01/2019 - 09/2013
1	Meconium Ileus 01/2021
1	Cholera 01/2021
1	Vipoma (WDHA) 01/2021
1	Hyperparathyroidism 01/2021
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2021
1	Asthma (Bronchial Asthma) 01/2019
1	Rhinosinusitis 01/2019
1	Adenoma (Adenomas) 01/2018
1	Hepatitis C 09/2013
1	Viremia 09/2013

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 01/2021
2	Loperamide (Imodium)FDA LinkGeneric 01/2021 - 01/2018
2	ChloridesIBA 01/2019 - 01/2018
2	AnionsIBA 01/2019 - 01/2018
1	Calcium-Sensing ReceptorsIBA 01/2021
1	Cinacalcet (Sensipar)FDA Link 01/2021
1	Amino Acids FDA Link 01/2021
1	Biological ProductsIBA 01/2021
1	NucleotidesIBA 01/2021
1	RNA Splice SitesIBA 01/2021
1	Chloride Channels (Chloride Channel)IBA 11/2019
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2019
1	AntiportersIBA 01/2019
1	tenapanorIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	vaniprevirIBA 09/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2013